Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 17.00
-0.21 (-1.22%)
May 12, 2026, 3:00 PM CST
SHA:688488 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -27.51 | -19.53 | -141.2 | -76.07 | -124.09 | -29.99 |
Depreciation & Amortization | 55.11 | 55.11 | 53.17 | 45.1 | 37.85 | 30.21 |
Other Amortization | 5.62 | 5.62 | 3.53 | 2.65 | 3.51 | 2.44 |
Loss (Gain) From Sale of Assets | -0.08 | -0.08 | - | -0.07 | -0.03 | -1.58 |
Asset Writedown & Restructuring Costs | 0.17 | 0.17 | 29.39 | 23.8 | 0.31 | - |
Loss (Gain) From Sale of Investments | -17.48 | -17.48 | -17.73 | -14.16 | -14.14 | -8.09 |
Provision & Write-off of Bad Debts | 0.37 | 0.37 | -3.34 | 3.72 | 8.87 | -2.49 |
Other Operating Activities | 29.05 | 59.93 | 54.72 | 11.77 | 36.21 | 10.89 |
Change in Accounts Receivable | -24.12 | -24.12 | 76.98 | -82.92 | -66.66 | 31.35 |
Change in Inventory | -21.53 | -21.53 | -44.28 | -52.4 | -74.62 | -36.7 |
Change in Accounts Payable | -26.22 | -26.22 | -14.34 | -8.84 | 118.87 | 3.87 |
Change in Other Net Operating Assets | 3.71 | 3.71 | -5.31 | -2.8 | - | - |
Operating Cash Flow | -21.23 | 17.63 | -37.5 | -166.22 | -92.55 | -12.37 |
Capital Expenditures | -45.23 | -47.93 | -44.56 | -71.2 | -140.3 | -94.78 |
Sale of Property, Plant & Equipment | 4.08 | 4.08 | 0.12 | 1.32 | 0.68 | 0.01 |
Cash Acquisitions | -5.04 | -5.04 | 16.35 | - | - | - |
Investment in Securities | 22.5 | 20.75 | 109 | 135.88 | -274.75 | 311.12 |
Other Investing Activities | -24.52 | 1.51 | 4.19 | 7.44 | 8.64 | 14.17 |
Investing Cash Flow | -48.21 | -26.63 | 85.1 | 73.44 | -405.72 | 230.53 |
Long-Term Debt Issued | - | 477.92 | 410.87 | 395.29 | 205 | - |
Total Debt Issued | 606.3 | 477.92 | 410.87 | 395.29 | 205 | - |
Long-Term Debt Repaid | - | -407.01 | -340.15 | -198.33 | -5.5 | -2.76 |
Total Debt Repaid | -374.28 | -407.01 | -340.15 | -198.33 | -5.5 | -2.76 |
Net Debt Issued (Repaid) | 232.02 | 70.91 | 70.72 | 196.96 | 199.5 | -2.76 |
Issuance of Common Stock | - | - | - | 5.48 | - | - |
Common Dividends Paid | -20.75 | -20.87 | -15.85 | -11.66 | -3.47 | -20.16 |
Other Financing Activities | -69.1 | - | - | - | - | - |
Financing Cash Flow | 142.18 | 50.04 | 54.86 | 190.78 | 196.03 | -22.92 |
Foreign Exchange Rate Adjustments | -0.17 | -0.1 | -0.01 | 0 | 0.47 | -0.15 |
Net Cash Flow | 72.57 | 40.94 | 102.46 | 98 | -301.77 | 195.08 |
Free Cash Flow | -66.46 | -30.3 | -82.06 | -237.43 | -232.85 | -107.15 |
Free Cash Flow Margin | -9.50% | -4.21% | -19.64% | -57.72% | -95.34% | -41.90% |
Free Cash Flow Per Share | -0.16 | -0.07 | -0.20 | -0.56 | -0.56 | -0.25 |
Cash Income Tax Paid | 113.01 | 100.19 | 22.87 | 22.29 | -6.67 | 11.66 |
Levered Free Cash Flow | -47.71 | -35.46 | -9.52 | -247.6 | -196.07 | -81.12 |
Unlevered Free Cash Flow | -37.95 | -25.69 | 0.08 | -240.24 | -193.62 | -80.97 |
Change in Working Capital | -66.46 | -66.46 | -16.04 | -162.97 | -41.05 | -13.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.